Skip to main content
Clinical Trials/NCT03784118
NCT03784118CompletedNot Applicable

Study on Complications After Arterial Line Placement and the Risk Factors in Children

Seoul National University Hospital2 sites in 1 country82 target enrollmentStarted: January 10, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
82
Locations
2
Primary Endpoint
Incidence of complications associated with arterial catheterization

Study Overview

Brief Summary

The purpose of this study is to find the risk factors for complications following arterial line catheterization. Ultrasonography is used to evaluate the size of artery which is cannulated, before and after catheterization. The complications include ischemia, bleeding, thrombosis and so on.

Detailed Description

artery observation with ultrasound

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Screening
Masking
None

Eligibility Criteria

Ages
— to 5 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Pediatric patients under 5 years of age who require invasive arterial pressure monitoring

Exclusion Criteria

  • Patients who do not need invasive arterial pressure monitoring

Outcomes

Primary Outcomes

Incidence of complications associated with arterial catheterization

Time Frame: within 5 days after arterial catheterization

Number of participants with complications following arterial catheterization. The complications include thrombus, ischemia, oozing or bleeding, and color change, etc. If any of these occur, it is assumed that complications have occurred.

Secondary Outcomes

  • Time-dependent changes in perfusion index(from arterial catheterization to the end of surgery)
  • Age as a risk factor(within 5 days after arterial catheterization)
  • Number of attempts as a risk factor(within 5 days after arterial catheterization)
  • Duration of catheterization as a risk factor(within 5 days after arterial catheterization)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Hee-Soo Kim

Professor

Seoul National University Hospital

Study Sites (2)

Loading locations...

Similar Trials